Strategic Partners A/S (CPH:STRAP)
Denmark
· Delayed Price · Currency is DKK 645.00
0.00 (0.00%)
Apr 28, 2026, 4:51 PM CET
Strategic Partners Employees
Strategic Partners had 1 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
1
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
309.00K DKK
Profits / Employee
-859.00K DKK
Market Cap
26.90M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Novo Nordisk | 69,505 |
| Genmab | 2,973 |
| Coloplast | 16,983 |
| ALK-Abelló | 2,613 |
| Gubra | 300 |
| BioPorto | 46 |
| ViroGates | 7 |
| Pharma Equity Group | 5 |
Strategic Partners News
- 5 years ago - Strategic Partners Earnings Call Transcript: H1 2021 - Transcripts
- 5 years ago - Strategic Partners Transcript: FDA Announcement - Transcripts
- 5 years ago - Strategic Partners Earnings Call Transcript: H2 2020 - Transcripts
- 6 years ago - Orphazyme closes its global offering, consisting of an initial public offering of American Depositary Shares in the U.S. and a concurrent private placement of ordinary shares in Europe - GlobeNewsWire
- 6 years ago - Orphazyme files final prospectus in connection with a global offering, consisting of initial public offering of American Despositary Shares in the United States and concurrent private placement of ordinary shares in Europe - GlobeNewsWire
- 6 years ago - Orphazyme publishes a prospectus regarding listing of 7,616,146 new ordinary shares on Nasdaq Copenhagen in connection with a global offering - GlobeNewsWire
- 6 years ago - Orphazyme prices its global offering, consisting of an initial public offering of American Depositary Shares in the U.S. and a concurrent private placement of ordinary shares in Europe - GlobeNewsWire
- 6 years ago - Orphazyme A/S provides update on previously announced global offering - GlobeNewsWire